| __timestamp | Amicus Therapeutics, Inc. | Insmed Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 20717000 | 31073000 |
| Thursday, January 1, 2015 | 47269000 | 43216000 |
| Friday, January 1, 2016 | 71151000 | 50679000 |
| Sunday, January 1, 2017 | 88671000 | 79171000 |
| Monday, January 1, 2018 | 127200000 | 168218000 |
| Tuesday, January 1, 2019 | 169861000 | 210796000 |
| Wednesday, January 1, 2020 | 156407000 | 203613000 |
| Friday, January 1, 2021 | 192710000 | 234273000 |
| Saturday, January 1, 2022 | 213041000 | 265784000 |
| Sunday, January 1, 2023 | 275270000 | 344501000 |
Cracking the code
In the competitive world of biotechnology, managing Selling, General, and Administrative (SG&A) expenses is crucial for financial health. Over the past decade, Insmed Incorporated and Amicus Therapeutics, Inc. have shown distinct trends in their SG&A expenditures. From 2014 to 2023, Insmed's SG&A costs surged by over 1,000%, peaking in 2023. In contrast, Amicus saw a more moderate increase of approximately 1,200% during the same period.
In 2014, Amicus spent about 21% less on SG&A than Insmed. However, by 2023, this gap widened, with Insmed's expenses exceeding Amicus's by nearly 25%. This trend suggests Insmed's aggressive expansion strategy, while Amicus appears to focus on steady growth. Understanding these dynamics can offer investors insights into each company's operational strategies and financial priorities.
Comparing SG&A Expenses: Amgen Inc. vs Insmed Incorporated Trends and Insights
Breaking Down SG&A Expenses: BeiGene, Ltd. vs Insmed Incorporated
Insmed Incorporated vs Walgreens Boots Alliance, Inc.: SG&A Expense Trends
Insmed Incorporated and Blueprint Medicines Corporation: SG&A Spending Patterns Compared
Insmed Incorporated or Exelixis, Inc.: Who Manages SG&A Costs Better?
Comparing SG&A Expenses: Insmed Incorporated vs Ultragenyx Pharmaceutical Inc. Trends and Insights
Cost Management Insights: SG&A Expenses for Insmed Incorporated and Geron Corporation
Amicus Therapeutics, Inc. or Vericel Corporation: Who Manages SG&A Costs Better?
Amicus Therapeutics, Inc. and HUTCHMED (China) Limited: SG&A Spending Patterns Compared
Comparing SG&A Expenses: Amicus Therapeutics, Inc. vs Protagonist Therapeutics, Inc. Trends and Insights
Breaking Down SG&A Expenses: Amicus Therapeutics, Inc. vs Mesoblast Limited
Selling, General, and Administrative Costs: Amicus Therapeutics, Inc. vs Travere Therapeutics, Inc.